| Dr Joseph Russell Madsen, MD | |
|
300 Longwood Ave, Children's Hospital Boston, Boston, MA 02115-5724 | |
| (617) 355-6005 | |
| (617) 730-0906 |
| Full Name | Dr Joseph Russell Madsen |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538149687 | NPI | - | NPPES |
| 3041034 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 56378 (Massachusetts) | Primary |
| Entity Name | Boston Pediatric Neurosurgical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871523753 PECOS PAC ID: 2163491978 Enrollment ID: O20040929000096 |
News Archive
Six experts from outside the federal government will join the National Biodefense Science Board (NBSB), a federal advisory committee which provides expert advice and guidance on preventing, preparing for, and responding to adverse health effects of public health emergencies to the Secretary of the U.S. Department of Health and Human Services and the HHS Assistant Secretary for Preparedness and Response (ASPR). The new members replace members whose 3-year terms expire Dec. 31.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
People with intermittent explosive disorder — a psychiatric illness characterized by impulsivity, hostility and recurrent aggressive outbursts — have elevated levels of two markers of systemic inflammation in their blood, according to a study involving nearly 200 subjects.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
An estimated 10 percent of older adults experience some form of abuse each year. However, the link between injuries and possible elder abuse may take months or years to establish and is often difficult to investigate due to poor documentation during prior medical visits.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Russell Madsen, MD 11 Broken Tree Rd, Newton, MA 02459-3415 Ph: () - | Dr Joseph Russell Madsen, MD 300 Longwood Ave, Children's Hospital Boston, Boston, MA 02115-5724 Ph: (617) 355-6005 |
News Archive
Six experts from outside the federal government will join the National Biodefense Science Board (NBSB), a federal advisory committee which provides expert advice and guidance on preventing, preparing for, and responding to adverse health effects of public health emergencies to the Secretary of the U.S. Department of Health and Human Services and the HHS Assistant Secretary for Preparedness and Response (ASPR). The new members replace members whose 3-year terms expire Dec. 31.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
People with intermittent explosive disorder — a psychiatric illness characterized by impulsivity, hostility and recurrent aggressive outbursts — have elevated levels of two markers of systemic inflammation in their blood, according to a study involving nearly 200 subjects.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
An estimated 10 percent of older adults experience some form of abuse each year. However, the link between injuries and possible elder abuse may take months or years to establish and is often difficult to investigate due to poor documentation during prior medical visits.
› Verified 9 days ago
Wenya Linda Bi, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 203-645-9485 Fax: 617-732-5500 | |
Dr. Justin Lee Massengale, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 7, Suite C, Boston, MA 02118 Phone: 617-638-8992 Fax: 617-638-8979 | |
Scellig S Stone, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-1484 | |
Dr. Mohammad Ali Aziz-sultan, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-6600 | |
Hormuzdiyar Henry Dasenbrock, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 7, Suite C, Boston, MA 02118 Phone: 617-638-8992 | |
Ganesh M Shankar, MD, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St., Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-5143 | |
Dr. Justin M Brown, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St # 745, Boston, MA 02114 Phone: 617-726-8582 Fax: 858-822-4715 |